Athanasia (Nasia) Apostolou
Research Senior Scientist Takeda
Seminars
Thursday 30th July 2026
Panel Discussion: Selecting the “Right” Tumor Model Amid New Regulatory Pressures – What Truly Drives Predictive Value, Confidence & Decision Making?
9:15 am
- Exploring how drug developers define the “right” tumor model for each decision point: clarifying what level of biological fidelity, readout quality, and mechanistic insight is truly needed to drive confident progression
- Understanding how in silico, in vitro, and in vivo systems complement one another, and when single‑model data is sufficient versus when convergence across multiple platforms is required to strengthen internal decision‑making
- Examining how well different models correlate with real clinical outcomes and what evidence is still needed for regulators and developers to fully trust emerging technologies as credible, decision‑enabling tools
